L-744832
L-744832 is a farnesyl transferase inhibitor. L-744832 effectively inhibits the farnesylation of H-Ras and N-Ras, but has little effect on K-Ras treatment. L-744832 not only directly targets the oncogenic pathway by inhibiting Ras farnesylation, but also enhances radiosensitivity by restoring TGF-β signaling through epigenetic reprogramming. L-744832 can induce cell cycle arrest and apoptosis. L-744832 can be used in combination therapy studies for Ras-driven tumors such as pancreatic cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 160141-09-3
- Formule: C26H45N3O6S2
- Masse moléculaire:559.78
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Activité biologique
-
Chemical Information
- Pureté et documentation
- Références
-
Help & FAQs
Activité biologique
|
H-Ras |
NRAS rG4 |
|
Cell Line
|
Type | Value | Description | References |
|---|---|---|---|---|
| DU-145 | IC50 |
78 μM
Compound: L-744832
|
Anticancer activity against hormone-resistant human DU145 cells assessed as cell proliferation after 72 hrs by MTT assay
Anticancer activity against hormone-resistant human DU145 cells assessed as cell proliferation after 72 hrs by MTT assay
|
[PMID: 21299244] |
| PC-3 | IC50 |
75 μM
Compound: L-744832
|
Anticancer activity against hormone-resistant human PC3 cells assessed as cell proliferation after 72 hrs by MTT assay
Anticancer activity against hormone-resistant human PC3 cells assessed as cell proliferation after 72 hrs by MTT assay
|
[PMID: 21299244] |
L-744832 (0.1-50 μM, 24-72 h) shows significant differences in sensitivity in Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells with IC50s of 1.3, 2.1, 12.3, 14.3 and > 50 μM[1].
L-744832 (0.1-50 μM, 72 h) arrest the sensitive cell lines (Panc-1, Capan-2, BxPC-3 and AsPC-1) in the G2/M phase of the cell cycle and the arrest occurs during the mitotic entry stage downstream of the G2/M checkpoint[1].
L-744832 (10 μM, 24-72 h) induces above five types of cell apoptosis, and the combination of radiotherapy can significantly increase the apoptosis rate of MIA PaCa-2 cells, while this effect is not observed in BxPC-3 cells[1][2].
L-744832 (0.1-10 μM) with ionizing radiation results in enhanced cytotoxicity in human pancreatic cancer cells[1].
L-744832 (5-10 μM) effectively inhibits the farnesylation of H-Ras and N-Ras and MIA PaCa-2 cells are more sensitive than BxPC-3 cells[2].
L-744832 (5-10 μM, 3-6 h) restores the expression of TGF-β type II receptor (RII) through regulating DNMT1, thereby re-establishing the tumor-suppressing function of TGF-β[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
-
Concentration:0.1, 0.5, 1, 10, 25 and 50 μM
-
Incubation Time:72 h
-
Result:Dose-dependent increased in G2/M phase accumulation and the proportion of G2/M phase cells in Panc-1 cells increased nearly threefold.
-
Cell Line:Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
-
Concentration:10 μM
-
Incubation Time:72 h
-
Result:Showed chromatin condensation and nuclear fragmentation.
Increased the apoptotic index in each group, and this occurred in both wild-type p53 (Capan-2) cells and mutant p53 (Panc-1) cells.
-
Cell Line:Panc-1, Capan-2, BxPC-3, AsPC-1 and CFPAC-1 cells
-
Concentration:10 μM
-
Incubation Time:72 h
-
Result:Significantly increased the activity of Cyclin B1/Cdc2 kinase.
-
Cell Line:MIA PaCa-2 cells
-
Concentration:10 μM
-
Incubation Time:3 and 6 h
-
Result:Activated the RII promoter to increase its mRNA levels.
Reduced the mRNA levels of DNMT1.
-
Cell Line:MIA PaCa-2 cells
-
Concentration:10 μM
-
Incubation Time:3 and 6 h
-
Result:Activated the RII promoter to increase its protein levels.
Reduced the protein levels of DNMT1.
Chemical Information
-
CAS No. 160141-09-3
-
Masse moléculaire 559.78
-
Formule C26H45N3O6S2
-
SMILES
O=C(OC(C)C)[C@@H](NC([C@@H](OC[C@@H](NC[C@@H](N)CS)[C@@H](C)CC)CC1=CC=CC=C1)=O)CCS(=O)(C)=O
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
[1]. Song SY, et al. K-Ras-independent effects of the farnesyl transferase inhibitor L-744,832 on cyclin B1/Cdc2 kinase activity, G2/M cell cycle progression and apoptosis in human pancreatic ductal adenocarcinoma cells. Neoplasia. 2000 May-Jun;2(3):261-72. [Content Brief]
[2]. Alcock RA, et al. Farnesyltransferase inhibitor (L-744,832) restores TGF-beta type II receptor expression and enhances radiation sensitivity in K-ras mutant pancreatic cancer cell line MIA PaCa-2. Oncogene. 2002 Nov 7;21(51):7883-90. [Content Brief]
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
L-744832 Related Classifications
HY-116428 Related Classifications
Powered by Bioz